When to Involve Your Provider: Safety and Individual Risk Assessment Persistent constipation lasting more than two weeks, abdominal pain, or signs of bowel obstruction warrant immediate provider contact
One animal was dead just before drug treatment at day 0 in tirzepatide treatment group
Patients: Request your healthcare provider to submit your prescription directly to us
Yes, current guidance avoids this drug class during pregnancy
In contrast, Zepbound, a form of tirzepatide, operates as a dual agonist for both the glucose-dependent insulinotropic polypeptide (GIP) and the GLP-1 receptor, promoting insulin secretion and sensations of satiety
It has few side effects such as digestive problems and is safe to consume as directed